RAB29 and Parkinson disease: Purlyte E., Dhekne H.S., Sarhan A.R., Gomez R., Lis P., Wightman M.,Martinez T.N., Tonelli F., Pfeffer S.R., Alessi D.R. Rab29 activationof the Parkinson’s disease-associated LRRK2 kinase.